Tag: infusion pumps

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 second quarter financial results before the market opens on Friday, August 1, 2025. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Embrace Active Site Care Patch Becomes First Medical Device Clinically Proven to Significantly Improve Lipohypertrophy (LH) in Insulin-Using Diabetes Patients

Findings from 16-week trial of novel compression patch will be shared for the first time at the 85th Scientific Sessions of the American Diabetes...

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsInfusion pumps

GCL SI Showcases Scenario-Based PV Solutions at SNEC 2026, Driving Application-Specific Solar Deployment and Low-Carbon Development

GWM TANK 700 Hi4-T Wins 11 of 13 Stages at 2026 Taklimakan Rally

Leetx to Showcase Full-Stack Self-Developed Assembly Technology at Automotive Manufacturing 2026 in Bangkok

Tag: infusion pumps

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

Embrace Active Site Care Patch Becomes First Medical Device Clinically Proven to Significantly Improve Lipohypertrophy (LH) in Insulin-Using Diabetes Patients

IoT Medical Devices Market worth US$154.74 billion by 2030 with 18.9% CAGR | MarketsandMarkets™.

Home Healthcare Market Share Worth $666.91 billion, Globally, by 2030 – Exclusive Study by The Research Insights

IV Therapy & Vein Access: Innovations Driving the Global Healthcare Market

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us